| Management Team |
Raphael Gernot KlingmannBSci, MBA (IESE) – CEO 20 years international pharma leadership positions in USA, Germany and South Africa with Bayer, Solvay and Abbott, including 8 years global strategy/business development director, 5 years as CEO of South African subsidiary. Molecular Biologist (USA) and Global Executive MBA (Spain-IESE). 
Lluís Ribas de PouplanaPhD – CSO & Founder ICREA Research Professor and PI at the Institute for Research in Biomedicine. Founder of Omnia Molecular, 18 years experience with Aminoacyl-tRNA synthetases. PhD Univ. of Edinburgh, Scientist M.I.T. (93-97), Assistant Professor The Scripps Research Institute (97-03). 
Oscar Rey PuiggròsPhD, MBA (ADE-Ramon Llull) – COO 8 years experience in Drug Discovery Laboratorios SALVAT & Omnia Molecular, background in Molecular Modeling, Theoretical Chemistry & Medicinal Chemistry. 
Maurici TorraMBA (ESADE) - CFO 10 years experience on SMEs management, includes 2 years on Venture Capital. 
Dariusch ManiPhD, MBA (IESE), Industry Advisor - BoD 20 years international experience pharmaceuticals & biotech, 12 years CEO, Schering AG, Madaus, LGP. Entrepreneur, consultant and professional healthcare investor. |
Omnia Molecular uses its proprietary platform and design expertise to synthesize and develop novel anti-infectives targeted at difficult-to-treat infections